NOVAGRAY
DEAD

Serial Number

88035570

Owner

NovaGray

Attorney

Pina Campagna

Filing Date

Jul 12, 2018

Add to watchlist:

No watchlists yet
View on USPTO

NOVAGRAY Trademark

Serial Number: 88035570 • Registration: 5831539

NOVAGRAY is a trademark filed by NovaGray on July 12, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NovaGray

Rond Point Benjamin Franklin
MONTPELLIER CEDEX 02 34960 , FR

Entity Type: 09

Trademark Details

Filing Date

July 12, 2018

Registration Date

August 13, 2019

Published for Opposition

February 26, 2019

Cancellation Date

February 27, 2026

Goods & Services

Medical services; medical diagnostic testing, monitoring and reporting services; medical analysis services for preventing side effects of radiotherapy cancer treatments; medical testing of urine, blood, hair follicles and breath; web-based oncological analysis services for medical diagnostic and treatment purposes; medical counseling services; medical assistance; hospital services *, none of the foregoing services offered in connection with radiation dose monitoring software *

Design, development, maintenance and updating of computer software; design, development, updating and maintenance of computer software for carrying out algorithms; computer programming in the medical field; computer programming services for medical applications; design and development of computer software for use in the field of medical technology; development of information system software and artificial intelligence computer system software for medical purposes; design, engineering, research, development and testing of computer software for medical applications; scientific research; design of computer software for database management; design, development, updating and maintenance of software and database systems; software as a service (SaaS) services, namely, hosting software for use by others for use in analyzing health data; medical research; biological research; research and development in the pharmaceutical and biotechnology field; medical laboratory services; software as a service (SAAS) services featuring computer software applications for analyzing health data; platform as a service (PAAS) featuring computer software platforms for analyzing health data *, all of the foregoing services limited to the field of analyzing biological samples for predicting the risk of a patient developing physical complications due to radiotheraphy treatment *

Pharmaceutical products for preventing side effects of radiotherapy cancer treatments; veterinary pharmaceutical products for preventing side effects of radiotherapy cancer treatments; chemical preparations for pharmaceutical or medical purposes, namely, for preventing side effects of radiotherapy cancer treatments; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical and veterinary use; diagnostic test equipment in the nature of medical diagnostic test strips for blood analysis for medical or veterinary use; chemical preparations for testing blood for medical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 27, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 13, 2024 REM1
AMENDMENT UNDER SECTION 7 - PROCESSED
Dec 27, 2021 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 27, 2021 APRE
SEC 7 REQUEST FILED
Aug 18, 2021 AMD7
TEAS SECTION 7 REQUEST RECEIVED
Aug 18, 2021 ES7R
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2019 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 7, 2019 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 13, 2019 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 6, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 23, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 11, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 11, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 11, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 11, 2019 CNEA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 8, 2019 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2019 CRFA
ASSIGNED TO LIE
Jan 7, 2019 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 3, 2019 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 3, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 6, 2018 GNRN
NON-FINAL ACTION E-MAILED
Nov 6, 2018 GNRT
NON-FINAL ACTION WRITTEN
Nov 6, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2018 NWOS
NEW APPLICATION ENTERED
Jul 16, 2018 NWAP